PPID and amyloidosis: However, molecules like CypD, appear to be capable of binding to one form with sufficient affinity to shift the monomer-multimer/fibril equilibrium in favour of the monomeric state, reducing the likelihood of pathogenic forms accumulating; this characteristic could present new opportunities to the design of therapies against amyloid diseases.